0 followers
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor... Read more
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
2 followers
Gilead Sciences
147 followers
Regeneron
111 followers
Illumina
76 followers
Agilent Technologies
76 followers
Verily Life Sciences
41 followers
Alexion Pharmaceuticals
40 followers
Explore companies